首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >Constitutive expression of p-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures.
【24h】

Constitutive expression of p-glycoprotein in normal lung alveolar epithelium and functionality in primary alveolar epithelial cultures.

机译:p-糖蛋白在正常肺泡上皮中的组成性表达和原发性肺泡上皮培养物中的功能。

获取原文
获取原文并翻译 | 示例
           

摘要

The multidrug resistant (MDR) transporter P-glycoprotein (P-gp) is constitutively expressed in normal tissues, where its spatial distribution defines it as an important element reducing the systemic exposure and tissue access of potentially harmful xenobiotics. We sought to determine whether P-gp is functionally expressed within alveolar epithelium of lung, in particular within the predominant cell type of this barrier, the alveolar epithelial (AE) type I cell. By immunohistochemistry, MDR-1/mdr-1 P-gp was localized to luminal membranes of AE type I epithelium within normal human and rat lung tissue. Using a primary rat cell culture model affording study of AE type II to AE type I differentiation, we observed increased expression (reverse transcription-polymerase chain reaction (RT-PCR), Western blot, and immunoflow cytometry techniques) of mdr-1a and mdr-1b P-gp in the cultures as they adopted an AE type I phenotype; freshly isolated AE type II cells were negative for mdr-1/P-gp. The functionality of P-gp within the AE cultures was demonstrated by a flow cytometric accumulation-retention assay using rhodamine-123 as substrate, and also by the polarized transport of vinblastine across confluent AE type I monolayers (basal-to-apical permeability was 3-fold that of apical-to-basal permeability), which was found to be comparable with the P-gp transport barrier presented by Caco-2 cell monolayers. The implications of localizing P-gp within alveolar epithelium is of significance to studies of fundamental respiratory cell biology as well as to further clarifying the nature of the barrier to xenobiotic transfer from alveolar airspace to pulmonary interstitium and capillary blood.
机译:多药抗性(MDR)转运蛋白P-糖蛋白(P-gp)在正常组织中组成性表达,其空间分布将其定义为减少潜在有害异源生物的全身暴露和组织通道的重要元素。我们试图确定P-gp是否在肺的肺泡上皮内,特别是在该屏障的主要细胞类型(肺泡上皮(AE)I型细胞)内功能性表达。通过免疫组织化学,MDR-1 / mdr-1 P-gp定位于正常人和大鼠肺组织内AE I型上皮的腔膜。使用提供从II型AE到I型AE分化研究的主要大鼠细胞培养模型,我们观察到了mdr-1a和mdr的表达增加(逆转录聚合酶链反应(RT-PCR),Western印迹和免疫流式细胞术技术) -1b P-gp在培养物中采用AE I型表型;新鲜分离的AE II型细胞对mdr-1 / P-gp呈阴性。使用罗丹明-123作为底物的流式细胞仪蓄积-保留测定法,以及长春碱在交汇的AE I型单层膜上的极化转运,证明了AE培养物中P-gp的功能(基底到顶端的通透性是3 -顶至基底的通透性的2倍)被发现与Caco-2细胞单层呈现的P-gp转运屏障相当。在肺泡上皮内定位P-gp的意义对基础呼吸细胞生物学的研究以及进一步阐明阻碍异种生物从肺泡空域转移至肺间质和毛细血管的屏障的性质具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号